Treatment regimens meeting ATS/IDSA guidelines [2] | Macrolide, ethambutol and rifamycin, optional parenteral aminoglycoside# |
Treatment regimens that potentially promote macrolide resistance [15] | Macrolide monotherapy |
Macrolide plus fluoroquinolone |
Macrolide plus rifampin |
Treatment regimens that are of unknown clinical significance [2] | Macrolide plus inhaled amikacin |
Macrolide plus linezolid |
Macrolide plus other agents¶ |
Treatment regimens that do not include macrolides | Ethambutol plus rifamycin |
Fluoroquinolone-based regimen |
Parenteral aminoglycoside-based regimen |
| Linezolid-based regimen |